| Biotechnology Industry | Healthcare Sector | Mr. Kan Song CEO | XSHE Exchange | CNE100002NZ1 ISIN |
| CN Country | 375 Employees | 27 May 2026 Last Dividend | 19 May 2022 Last Split | - IPO Date |
Yantai Zhenghai Biotechnology Co., Ltd. is a pioneering entity in the Chinese biotechnology landscape, specializing in the innovative domain of regenerative medical materials. Established in 2003 and stationed in Yantai, China, the company has carved a niche for itself through its dedicated focus on research and development, production, and the marketing of advanced biological materials. These biotech innovations are geared towards facilitating healing and regeneration within the human body, placing Yantai Zhenghai Biotechnology at the forefront of medical science advancements in China.